The upregulated Rosa26‐Lmo2 + Sca1‐Cre signature shows a significant enrichment in the human T‐ALL group which is in accordance with the human T‐ALL situation wherein the expression of LMO2 is present throughout in tumor cells. The gene discussed is LMO2; the disease is acute lymphoblastic leukemia.